FDA moves to make opioid overdose antidote an over-the-counter drug.
On Tuesday, the FDA issued a Federal Register notice that could lead to some prescription naloxone products getting approved forsales. The notice could also encourage development of new nonprescription naloxone products.
The notice cites a preliminary assessment that a naloxone nasal spray and an autoinjector "may be approvable as safe and effective for nonprescription use." However, it isn't a final decision or a mandate to make naloxone products available without a prescription.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. FDA staff flags unclear benefits of Ardelyx's kidney disease drugU.S. Food and Drug Administration staff reviewers on Monday raised concerns over unclear benefits of Ardelyx Inc's drug for kidney disease patients, but the company's shares rose 20% on expectations over a possible approval.
Read more »
FDA warns of rise in reports of child poisonings linked to cough medicineReports to poison control centers about children ingesting a prescription drug called benzonatate rose from 2010 through 2018.
Read more »
FDA Developing Plan to Guard Against Bacteria Outbreaks in Baby FormulaThe Food and Drug Administration is developing a plan to guard against cronobacter bacteria outbreaks in baby formula
Read more »
FDA takes steps to authorize some naloxone products for over-the-counter saleThe U.S. Food and Drug Administration has issued a notice that could help increase access to overdose-reversing naloxone drug products without the need for a prescription, paving the way to make more of them available for over-the-counter use.
Read more »
New FDA warning links cough medicine to rise in child poisoningsCalls to poison control centers reporting the ingestion of prescription cough medicine by children increased by 158% between 2010 and 2018, according to a study published FDA.
Read more »